Surgeon-Centric Innovation FH Ortho is a rapidly growing medical device company focused on surgeon-first innovations in shoulder, calcaneal, and knee soft-tissue solutions, suggesting strong opportunities to position product trials and surgeon education programs to drive adoption.

Distinct Product Line Key offerings include Arrow Prime Dual-Platform Shoulder System, Calcanail percutaneous calcaneal fixation, and CoLS soft-tissue knee repair, indicating multiple entry points for account specialization and cross-sell across orthopedics.

Clinical History Leverage With a long clinical history for Arrow Prime and a track record in shoulder arthroplasty, FH Ortho can leverage existing clinical data, case studies, and surgeon success stories to support new product introductions and expand indications.

SMB Growth Target Revenue is in the $1M–$10M range and employee count is 51–200, signaling mid-market scale ideal for direct sales outreach, regional partnerships, and scalable training programs to accelerate market penetration.

Partner & Expansion Potential Past partnerships with service-disabled veteran-owned Red One Medical and a spine-focused unit indicate openness to collaborations, distribution deals, and channel strategies to broaden market access and accelerate adoption.